- Home
- CRBU vs PNI Comparison
CRBU vs PNI Comparison
Compare CRBU & PNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBU
- PNI
- Stock Information
- Founded
- CRBU 2011
- PNI 2002
- Country
- CRBU United States
- PNI United States
- Employees
- CRBU N/A
- PNI N/A
- Industry
- CRBU Medicinal Chemicals and Botanical Products
- PNI Trusts Except Educational Religious and Charitable
- Sector
- CRBU Health Care
- PNI Finance
- Exchange
- CRBU Nasdaq
- PNI Nasdaq
- Market Cap
- CRBU 93.0M
- PNI 82.7M
- IPO Year
- CRBU 2021
- PNI N/A
- Fundamental
- Price
- CRBU $0.74
- PNI $6.69
- Analyst Decision
- CRBU Strong Buy
- PNI
- Analyst Count
- CRBU 5
- PNI 0
- Target Price
- CRBU $11.80
- PNI N/A
- AVG Volume (30 Days)
- CRBU 1.1M
- PNI 26.4K
- Earning Date
- CRBU 05-06-2025
- PNI 01-01-0001
- Dividend Yield
- CRBU N/A
- PNI 4.76%
- EPS Growth
- CRBU N/A
- PNI N/A
- EPS
- CRBU N/A
- PNI N/A
- Revenue
- CRBU $9,994,000.00
- PNI N/A
- Revenue This Year
- CRBU N/A
- PNI N/A
- Revenue Next Year
- CRBU $163.34
- PNI N/A
- P/E Ratio
- CRBU N/A
- PNI N/A
- Revenue Growth
- CRBU N/A
- PNI N/A
- 52 Week Low
- CRBU $0.66
- PNI $6.03
- 52 Week High
- CRBU $4.21
- PNI $7.89
- Technical
- Relative Strength Index (RSI)
- CRBU 34.01
- PNI 29.75
- Support Level
- CRBU $0.71
- PNI $6.64
- Resistance Level
- CRBU $0.94
- PNI $6.91
- Average True Range (ATR)
- CRBU 0.10
- PNI 0.15
- MACD
- CRBU 0.00
- PNI -0.03
- Stochastic Oscillator
- CRBU 23.44
- PNI 25.00
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.
About PNI Pimco New York Municipal Income Fund II of Beneficial Interest
PIMCO New York Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State and New York City income tax. The fund portfolio of investments consists of investments in different sectors such as education, transportation, healthcare, and others.